An “all-in-one” treatment and imaging nanoplatform for breast cancer with photothermal nanoparticles

Yuping Fu,Hongmei Zhang,Jiahui Ye,Changrong Chen,Yaxuan Yang,Baojuan Wu,Xi Yin,Jiajun Shi,Yun Zhu,Cheng Zhao,Weijie Zhang

DOI: https://doi.org/10.1039/d3na00814b

IF: 5.598

2024-01-01

Nanoscale Advances

Abstract:This nanoplatform achieved a combination of magnetically guided photothermal and chemotherapy, providing an opportunity for imaging and tracking therapeutic efficacy.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry

What problem does this paper attempt to address?

This paper aims to address the issues of inefficiency and inability to track treatment effects in the nano-drug delivery systems used for breast cancer treatment. Specifically, the current nano-drug delivery systems have low efficacy in tumor treatment due to the presence of biological barriers, and it is difficult to track the distribution of drugs within the body. This limits clinicians' ability to judge treatment effects and adjust drug dosages, thereby hindering the further application and translation of nano-platforms.

To tackle this challenge, the research team developed an "integrated" nano-platform for combined therapy and imaging. This platform co-encapsulates the photothermal therapeutic agent IR780, the passively targeted drug OA@Fe3O4, and the chemotherapeutic drug paclitaxel, enhancing local drug enrichment under magnetic navigation guidance. Additionally, the luminescent properties of IR780 allow for real-time drug tracking. Experimental results show that these nanoparticles exhibit significant anti-tumor effects in both in vivo and in vitro experiments, indicating their great potential for future biomedical applications and clinical decision-making.